Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2025-12-25 @ 5:22 PM
NCT ID:
NCT05628103
Pre Assignment Details:
A total of 243 participants were screened, of which 101 participants entered the study, and all 101 participants received at least one dose of SEP-363856 in the 8-week treatment period.
Recruitment Details:
Participants took part in the study at 26 clinical sites in the United States (US) from 19 December 2022 to 01 April 2024.
Study:
NCT05628103
Study Brief:
Results Section:
NCT05628103